Altered growth in male peroxisome proliferator-activated receptor gamma (PPARgamma) heterozygous mice: involvement of PPARgamma in a negative feedback regulation of growth hormone action.

Rieusset, Jennifer; Seydoux, Josiane; Anghel, Silvia I; Escher, Pascal; Michalik, Liliane; Soon Tan, Nguan; Metzger, Daniel; Chambon, Pierre; Wahli, Walter; Desvergne, Béatrice (2004). Altered growth in male peroxisome proliferator-activated receptor gamma (PPARgamma) heterozygous mice: involvement of PPARgamma in a negative feedback regulation of growth hormone action. Molecular endocrinology, 18(10), pp. 2363-2377. Endocrine Society 10.1210/me.2003-0325

[img] Text
mend2363.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (521kB) | Request a copy

The peroxisome proliferator-activated receptor gamma (PPARgamma) plays a major role in fat tissue development and physiology. Mutations in the gene encoding this receptor have been associated to disorders in lipid metabolism. A thorough investigation of mice in which one PPARgamma allele has been mutated reveals that male PPARgamma heterozygous (PPARgamma +/-) mice exhibit a reduced body size associated with decreased body weight, reflecting lean mass reduction. This phenotype is reproduced when treating the mice with a PPARgamma- specific antagonist. Monosodium glutamate treatment, which induces weight gain and alters body growth in wild-type mice, further aggravates the growth defect of PPARgamma +/- mice. The levels of circulating GH and that of its downstream effector, IGF-I, are not altered in mutant mice. However, the IGF-I mRNA level is decreased in white adipose tissue (WAT) of PPARgamma +/- mice and is not changed by acute administration of recombinant human GH, suggesting an altered GH action in the mutant animals. Importantly, expression of the gene encoding the suppressor of cytokine signaling-2, which is an essential negative regulator of GH signaling, is strongly increased in the WAT of PPARgamma +/- mice. Although the relationship between the altered GH signaling in WAT and reduced body size remains unclear, our results suggest a novel role of PPARgamma in GH signaling, which might contribute to the metabolic disorder affecting insulin signaling in PPARgamma mutant mice.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology

UniBE Contributor:

Escher, Pascal

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0888-8809

Publisher:

Endocrine Society

Language:

English

Submitter:

PD Dr. Pascal Escher

Date Deposited:

10 Jul 2017 16:18

Last Modified:

31 Jul 2017 08:31

Publisher DOI:

10.1210/me.2003-0325

PubMed ID:

15231871

BORIS DOI:

10.7892/boris.101758

URI:

https://boris.unibe.ch/id/eprint/101758

Actions (login required)

Edit item Edit item
Provide Feedback